Sexual Dissatisfaction in Postmenopausal Women Not Linked to Cardiovascular Disease
New study published in The American Journal of Medicine
New York, April 2, 2008 – Although sexual dysfunction in some men is predictive of cardiovascular disease, this association has never been examined in women. In an article published in the April 2008 issue of The American Journal of Medicine, researchers found no increased prevalence or incidence of cardiovascular disease among postmenopausal sexually active female subjects who were dissatisfied with their sexual activity.
Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) and collaborators nationwide examined data from over 93,000 women in the Women’s Health Initiative Observational Study. Participants were sexually active postmenopausal women aged 50 to 79 years, recruited at 40 clinical centers throughout the United States and followed for 8-12 years. Based on responses to a baseline survey, subjects were classified as sexually satisfied or dissatisfied.
Researchers identified cardiovascular disease as a self-reported history of acute myocardial infarction, stroke, or coronary revascularization procedure. Related cardiovascular problems, including congestive heart failure, peripheral arterial disease and angina were also examined.
According to researchers, there was a modest association between being dissatisfied with sexual activity and having peripheral arterial disease, and angina was decreased among those dissatisfied with sexual activity. However, there was no association between sexual dissatisfaction and the presence of any other form of cardiovascular disease including heart attack or stroke.
Writing in the article, Jennifer McCall-Hosenfeld, MD, MSc, a fellow in the Department of General Internal Medicine at BMC and Women’s Health at BUSM, states, “In men, erectile dysfunction is a manifestation of cardiovascular disease, and can predict the development of adverse cardiovascular outcomes such as heart attack. In our study, we used decreased sexual satisfaction as a rough proxy measure for sexual dysfunction, and controlled for lifestyle issues and other factors that might impact sexual satisfaction. We did not find that sexual satisfaction predicted cardiovascular disease in the future.”
The article is “Sexual Satisfaction and Cardiovascular Disease: The Women’s Health Initiative” by Jennifer S. McCall-Hosenfeld, MD, MSc, Karen M. Freund, MD, MPH, Claudine Legault, PhD, Sarah Jaramillo, MS, Barbara B. Cochrane, PhD, RN, JoAnn E. Manson, MD, DPH, Nanette K. Wenger, MD, Charles B. Eaton, MD, S. Gene McNeeley, MD, Beatriz L. Rodriguez, MD, PhD, Denise Bonds, MD, MPH. It appears in The American Journal of Medicine, Volume 121, Issue 4 (April 2008) published by Elsevier.
The Women’s Health Initiative program was funded by the National Heart, Lung and Blood Institute of the National Institutes of Health, U.S. Department of Health and Human Services. Jennifer McCall-Hosenfeld was supported by a Department of Veterans Affairs Special Fellowship in the Health Issues of Women Veterans.
# # #
Full text of the article featured above is available upon request. Contact firstname.lastname@example.org to obtain a copy. To schedule an interview contact Allison Rubin at (617) 638-8491 or email@example.com.
About The American Journal of Medicine
The American Journal of Medicine, known as the “Green Journal,” is one of the oldest and most prestigious general internal medicine journals published in the United States. AJM, the official journal of The Association of Professors of Medicine, a group comprised of chairs of departments of internal medicine at 125-plus U.S. medical schools, publishes peer-reviewed, original scientific studies that have direct clinical significance. The information contained in this article in The American Journal of Medicine is not a substitute for medical advice or treatment, and the Journal recommends consultation with your physician or healthcare professional. AJM is published by Elsevier.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
+1 212 633 3944